APA (7th ed.) Citation

Montagna, D. R., Duarte, A., Chiarella, P., Rearte, B., Bustuoabad, O. D., Vermeulen, M., & Ruggiero, R. A. (2022). Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor. BMC Cancer, 22(1), 1. https://doi.org/10.1186/s12885-022-09941-2

Chicago Style (17th ed.) Citation

Montagna, Daniela R., Alejandra Duarte, Paula Chiarella, Bárbara Rearte, Oscar D. Bustuoabad, Mónica Vermeulen, and Raúl A. Ruggiero. "Inhibition of Hyperprogressive Cancer Disease Induced by Immune-checkpoint Blockade upon Co-treatment with Meta-tyrosine and P38 Pathway Inhibitor." BMC Cancer 22, no. 1 (2022): 1. https://doi.org/10.1186/s12885-022-09941-2.

MLA (9th ed.) Citation

Montagna, Daniela R., et al. "Inhibition of Hyperprogressive Cancer Disease Induced by Immune-checkpoint Blockade upon Co-treatment with Meta-tyrosine and P38 Pathway Inhibitor." BMC Cancer, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12885-022-09941-2.